Inlet Private Wealth LLC Has $7.01 Million Holdings in DaVita Inc. (NYSE:DVA)

Inlet Private Wealth LLC decreased its holdings in shares of DaVita Inc. (NYSE:DVA) by 0.5% in the 3rd quarter, Holdings Channel reports. The fund owned 42,740 shares of the company’s stock after selling 200 shares during the period. DaVita accounts for 1.8% of Inlet Private Wealth LLC’s investment portfolio, making the stock its 16th largest holding. Inlet Private Wealth LLC’s holdings in DaVita were worth $7,006,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Blue Trust Inc. increased its holdings in DaVita by 58.6% in the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock worth $29,000 after purchasing an additional 78 shares in the last quarter. Newbridge Financial Services Group Inc. acquired a new position in shares of DaVita in the fourth quarter valued at approximately $30,000. Family Firm Inc. bought a new position in DaVita in the 2nd quarter valued at approximately $43,000. Versant Capital Management Inc boosted its position in DaVita by 90.6% during the 2nd quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock worth $45,000 after buying an additional 155 shares during the period. Finally, Friedenthal Financial acquired a new stake in DaVita during the 2nd quarter worth approximately $48,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Javier Rodriguez sold 32,176 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $155.93, for a total value of $5,017,203.68. Following the transaction, the chief executive officer now owns 905,659 shares of the company’s stock, valued at approximately $141,219,407.87. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Javier Rodriguez sold 32,176 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $155.93, for a total value of $5,017,203.68. Following the completion of the sale, the chief executive officer now directly owns 905,659 shares of the company’s stock, valued at approximately $141,219,407.87. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Michael David Staffieri sold 9,539 shares of the company’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the completion of the sale, the chief operating officer now owns 241,945 shares of the company’s stock, valued at approximately $36,299,008.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 173,482 shares of company stock worth $27,387,069 over the last three months. 2.00% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on DVA shares. Truist Financial raised their price target on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research note on Monday, October 7th. UBS Group raised their target price on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. TD Cowen upped their price target on DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. Finally, Bank of America raised their price objective on DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $159.00.

DaVita Stock Down 1.8 %

DVA traded down $2.95 during midday trading on Thursday, hitting $161.87. The company had a trading volume of 219,215 shares, compared to its average volume of 807,013. The company has a market capitalization of $13.58 billion, a price-to-earnings ratio of 17.30, a PEG ratio of 0.93 and a beta of 0.87. The stock’s 50 day moving average price is $155.89 and its 200 day moving average price is $144.28. The company has a quick ratio of 1.12, a current ratio of 1.16 and a debt-to-equity ratio of 9.94. DaVita Inc. has a 52 week low of $75.14 and a 52 week high of $168.50.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.47 by $0.12. The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.15 billion. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The firm’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the prior year, the business earned $2.08 EPS. On average, research analysts anticipate that DaVita Inc. will post 9.99 earnings per share for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.